[This is an English translation prepared for reference purpose only. Should there be any inconsistency between the translation and the original Japanese text, the latter shall prevail.]
February 14, 2022
Consolidated Financial Results
for the Fiscal Year Ended December 31, 2021
Name of the Listed Company: | JAPAN TOBACCO INC. (Stock Code: 2914) |
Listed Stock Exchange: | Tokyo Stock Exchange |
URL: | https://www.jti.co.jp/ |
Representative: | Masamichi Terabatake, Representative Director and President, |
Chief Executive Officer | |
Contact: | Hiroyuki Fukuda, Senior Vice President, Corporate Communications |
Telephone: | +81-3-6636-2914 |
Scheduled date of Annual General Meeting of Shareholders: March 23, 2022
Scheduled date to file Securities Report: March 23, 2022
Scheduled starting date of the dividend payments: March 24, 2022
Drawing up supplementary documents on financial results: Yes
Holding investors' meeting: Yes (for analysts and institutional investors)
(Yen amounts are rounded to the nearest million, unless otherwise noted.)
1. Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 (from
January 1, 2021 to December 31, 2021)
(1) Consolidated Operating Results | (Percentages indicate year-on-year changes.) | ||||||||
Revenue | Operating profit | Profit before income taxes | Profit for the year | ||||||
Year ended | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | |
December 31, 2021 | 2,324,838 | 11.1 | 499,021 | 6.4 | 472,390 | 12.5 | 340,181 | 9.0 | |
December 31, 2020 | 2,092,561 | (3.8) | 469,054 | (6.6) | 420,063 | (9.7) | 312,029 | (13.7) | |
Profit attributable to | Comprehensive income | ||||||||
owners of the parent | Basic earnings per share | Diluted earnings per share | |||||||
for the year | |||||||||
company | |||||||||
Year ended | Millions of yen | % | Millions of yen | % | Yen | Yen | |||
December 31, 2021 | 338,490 | 9.1 | 540,258 | 306.6 | 190.76 | 190.68 | |||
December 31, 2020 | 310,253 | (10.9) | 132,883 | (63.7) | 174.88 | 174.80 | |||
Ratio of profit to equity | Ratio of profit before | Ratio of operating profit | |||||||
attributable to owners of | income taxes to total | ||||||||
to revenue | |||||||||
the parent company | assets | ||||||||
Year ended | % | % | % | ||||||
December 31, 2021 | 12.7 | 8.5 | 21.5 | ||||||
December 31, 2020 | 12.0 | 7.7 | 22.4 | ||||||
Reference: Share of profit (loss) in investments accounted for using the equity method: | |||||||||
Fiscal year ended December 31, 2021: | ¥3,997 million; | Fiscal year ended December 31, 2020: ¥4,042 million |
(2) Consolidated Financial Position
Equity attributable to | Ratio of equity | Equity attributable to | |||
attributable to owners | |||||
Total assets | Total equity | owners of the parent | owners of the parent | ||
of the parent company | |||||
company | company per share | ||||
to total assets | |||||
As of | Millions of yen | Millions of yen | Millions of yen | % | Yen |
December 31, 2021 | 5,774,209 | 2,886,081 | 2,809,258 | 48.7 | 1,583.10 |
December 31, 2020 | 5,381,382 | 2,599,495 | 2,522,834 | 46.9 | 1,421.92 |
(3) Consolidated Cash Flows
Net cash flows | Net cash flows | Net cash flows | Cash and cash | |
from (used in) | from (used in) | from (used in) | equivalents at the end of | |
operating activities | investing activities | financing activities | the year | |
Year ended | Millions of yen | Millions of yen | Millions of yen | Millions of yen |
December 31, 2021 | 598,909 | (97,499) | (353,138) | 721,731 |
December 31, 2020 | 519,833 | 5,354 | (297,404) | 538,844 |
2. Cash Dividends
Annual dividends per share | Ratio of dividends | |||||||
to equity | ||||||||
First | Third | Total amount of | Payout ratio | attributable to | ||||
Second | Fiscal year- | dividends (total) | (consolidated) | owners of the | ||||
quarter- | quarter- | Total | ||||||
quarter-end | end | parent company | ||||||
end | end | (consolidated) | ||||||
Yen | Yen | Yen | Yen | Yen | Millions of yen | % | % | |
Year ended | ||||||||
December | - | 77.00 | - | 77.00 | 154.00 | 273,234 | 88.1 | 10.5 |
31, 2020 | ||||||||
Year ended | ||||||||
December | - | 65.00 | - | 75.00 | 140.00 | 248,433 | 73.4 | 9.3 |
31, 2021 | ||||||||
Year ending | ||||||||
December | - | 75.00 | - | 75.00 | 150.00 | 74.8 | ||
31, 2022 | ||||||||
(Forecast) |
3. Consolidated Earnings Forecasts for the Fiscal Year Ending December 31, 2022 (January 1, 2022 to December 31, 2022)
(Percentages indicate year-on-year changes.) | |||||||
Profit attributable to | Basic earnings | ||||||
Revenue | Operating profit | owners of the parent | |||||
per share | |||||||
company | |||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | |
Year ending | 2,315,000 | (0.4) | 534,000 | 7.0 | 356,000 | 5.2 | 200.62 |
December 31, 2022 | |||||||
[Additional Information] Growth rate in adjusted operating profit at constant rates of exchange:
The Group has set its group-wide target for annual average growth rate in adjusted operating profit at constant rates of exchange, at mid to high single-digit over the mid- to long-term, and will continue to pursue this goal.
(Percentages indicate year-on-year changes.)
Adjusted operating profit at constant rates of exchange | |||
Millions of yen | % | ||
Year ended | 598,414 | 22.9 | |
December 31, 2021 | |||
Year ending | 635,000 | 4.0 | |
December 31, 2022 (Forecast) | |||
The Group also discloses certain non-GAAP financial measures that are not required or defined under IFRS, which is the accounting standard the Company applies. These non-GAAP financial measures are used internally to manage each of the business operations to understand their underlying performance, in view of the Group's target for mid- to long-term sustainable growth, and the Group believes that these financial measures are useful information for users of the financial statements to assess the Group's performance. For details of these financial measures, please refer to "1. Business Results" in attached materials.
For detailed information on the consolidated financial results, please refer to the materials for investors' meeting that were released on the Company's website (https://www.jt.com/investors/) on February 14, 2022.
Notes
- Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in change in scope of consolidation): None
- Changes in accounting policies and changes in accounting estimates
- Changes in accounting policies due to revisions in accounting standards under IFRS: Yes
- Changes in accounting policies due to other reasons: None
- Changes in accounting estimates: None
For details, please refer to "3. Consolidated Financial Statements and Major Notes (IFRS), (6) Notes to consolidated financial statements (Changes in accounting policies)."
-
Number of shares issued (ordinary shares)
a. Total number of shares issued at the end of the period (including treasury shares)
As of December 31, 2021 | 2,000,000,000 | shares |
As of December 31, 2020 | 2,000,000,000 | shares |
- Number of treasury shares at the end of the period
As of December 31, 2021 | 225,475,301 | shares |
As of December 31, 2020 | 225,754,671 | shares |
- Average number of shares during the period
Fiscal year ended December 31, 2021 | 1,774,419,289 | shares |
Fiscal year ended December 31, 2020 | 1,774,128,185 | shares |
- Financial results reports are exempt from audit conducted by certified public accountants or an audit corporation.
-
Proper use of earnings forecasts, and other special matters
The forward-looking statements, including earnings forecasts, contained in these materials are based on information currently available to the Company and on certain assumptions and suppositions deemed to be reasonable by the Company. Actual business and other results may differ substantially due to various factors. These forward-looking statements are not intended to be construed as our assurance for it to materialize in the future. Please refer to "FORWARD-LOOKING STATEMENTS" for the suppositions that form the assumptions for earnings forecasts and cautions concerning the use of earnings forecasts.
Attached Materials | ||
Index | ||
1. Business Results ..................................................................................................................................... | 2 | |
(1) | Consolidated Business Results ............................................................................................................ | 2 |
(2) | Consolidated Financial Position .......................................................................................................... | 4 |
(3) | Outlook for the Next Fiscal Year ......................................................................................................... | 5 |
(4) | Basic policy on Profit Distribution and Dividends for Fiscal Years 2021 and 2022............................... | 6 |
2. Basic Principle on the Choice of Accounting Standards........................................................................... | 7 | |
3. Consolidated Financial Statements and Major Notes (IFRS).................................................................... | 9 | |
(1) | Consolidated Statement of Financial Position ...................................................................................... | 9 |
(2) | Consolidated Statement of Income and Consolidated Statement of Comprehensive Income ............... | 11 |
(3) | Consolidated Statement of Changes in Equity ................................................................................... | 13 |
(4) | Consolidated Statement of Cash Flows.............................................................................................. | 15 |
(5) | Notes on Premise of Going Concern.................................................................................................. | 17 |
(6) | Notes to Consolidated Financial Statements ...................................................................................... | 17 |
(Changes in accounting policies).......................................................................................................... | 17 | |
(Additional information) ...................................................................................................................... | 17 | |
(Segment information) ......................................................................................................................... | 18 | |
(Per share information) ........................................................................................................................ | 23 | |
(Significant subsequent events) ............................................................................................................ | 24 | |
4. Non-consolidated Financial Statements and Major Notes (Japanese GAAP) .......................................... | 25 | |
(1) | Non-consolidated Balance Sheet ....................................................................................................... | 25 |
(2) | Non-consolidated Statement of Income ............................................................................................. | 28 |
(3) | Non-consolidated Statement of Changes in Net Assets ...................................................................... | 29 |
(4) | Notes on Premise of Going Concern.................................................................................................. | 31 |
- 1 -
1. Business Results
(Non-GAAP Financial Measures)
The Group also discloses certain non-GAAP financial measures that are not required or defined under IFRS, which is the accounting standard the Company applies. These non-GAAP financial measures are used internally to manage each of the business operations to understand their underlying performance, in view of the Group's target for mid- to long-term sustainable growth, and the Group believes that these financial measures are useful information for users of the financial statements to assess the Group's performance.
Adjusted operating profit
Adjusted operating profit presented is operating profit (loss) less amortization cost of acquired intangibles arising from business acquisitions and adjustment items (income and costs). Adjustment items (income and costs) are impairment losses on goodwill, restructuring income and costs, and other items.
Furthermore, adjusted operating profit at constant rates of exchange is also presented as additional information. This is a financial measurement that excludes foreign exchange effects by translating and calculating adjusted operating profit for the current fiscal year in the International Tobacco Business using the foreign exchange rates of the previous fiscal year. The Group has set its group-wide target for annual average growth rate in adjusted operating profit at constant FX, at mid to high single digit over the mid- to long-term, and will continue to pursue this goal.
The Group makes accounting adjustments to the financial statements of subsidiaries that operate in hyperinflationary economies according to the requirements stipulated in IAS 29 "Financial Reporting in Hyperinflationary Economies" (hereinafter referred to as "IAS 29"). However, the impact of IAS 29 is not included in adjusted operating profit at constant FX.
(1) Consolidated Business Results a. General summary
(Billions of yen) | |||
Fiscal year ended | Fiscal year ended | Change | |
December 31, 2020 | December 31, 2021 | ||
Revenue | 2,092.6 | 2,324.8 | 11.1% |
Adjusted operating profit | 487.0 | 610.4 | 25.4% |
Operating profit | 469.1 | 499.0 | 6.4% |
Profit attributable to owners of the parent | 310.3 | 338.5 | 9.1% |
company | |||
Adjusted operating profit at constant rates of | 487.0 | 598.4 | 22.9% |
exchange | |||
Revenue
Revenue increased by 11.1% from the previous year to ¥2,324.8 billion, with declines in the Processed Food Business being offset by increases in the International Tobacco Business, the Domestic Tobacco Business and the Pharmaceutical Business.
Adjusted operating profit
Adjusted operating profit at constant rates of exchange increased by 22.9% from the previous year driven by growth in the International Tobacco Business, the Domestic Tobacco Business and the Processed Food Business, partially offset by a decrease in the Pharmaceutical Business. Adjusted operating profit including foreign exchange effects increased by 25.4% from the previous fiscal year to ¥610.4 billion, mainly due to the favorable foreign exchange effects in the International Tobacco Business.
- 2 -
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Japan Tobacco Inc. published this content on 14 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 February 2022 08:32:06 UTC.